mHealth Market Research Report Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2030

Global mHealth Market Overview

MHealth Market Size was valued at USD 58.2 billion in 2022. The mHealth market industry is projected to grow from USD 64.8 Billion in 2023 to USD 123.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.30% during the forecast period (2023 - 2030). The market is expanding due to the rising use of linked devices and mHealth apps for treating infectious and chronic diseases. The development of enhanced mobile solutions is another main market driver propelling the mHealth market's expansion.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

mHealth Market Trends

Increasing demand for smartphones and other wireless technology to propel market growth

Global demand for smartphones is one of the main drivers boosting the mobile health market's revenue growth. According to the Center for Technology Innovation, many healthcare-related services are now accessible through wireless multimedia thanks to the widespread ownership of smartphones, cell phones, and tablets. This is anticipated to accelerate the uptake of mHealth services. A rise in the demand for better point-of-care communication and accurate information is driving mobile health adoption. A clinical environment is best served by the communication capabilities of hospital information systems (HISs), electronic health records (EHRs), clinical decision support systems (CDSS), electronic medical records (EMRs), picture archiving and communication systems (PACS), and laboratory information systems (LIS). Increased use of these systems is anticipated to benefit the global market. Thus, this factor is driving the market CAGR for mHealth.

Figure 1: Number of smartphone users worldwide

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

The mHealth devices are being manufactured for wide use for the patients. Furthermore, the public's health is at risk because of the COVID-19 outbreak. Governments of various nations took several emergency measures to stop the disease's spread, with the World Health Organization's (WHO) COVAX effort being one of the most aggressively implemented. Worldwide, COVID-19 vaccination is now required for all individuals. Additionally, governments in several nations have directed their travel and tourism divisions to rigorously verify visitors' vaccination records before allowing them entry. Patients now have access to various healthcare providers, making telemedicine one alternative means of providing them with high-quality medical care. Mobile health (Health) applications have increased the use of telemedicine to link patients and healthcare providers in response to the COVID-19 epidemic. Most of the population was reluctant to leave their quarantine facilities and homes for any reason during the COVID-19 pandemic, so the rapid growth of mobile technologies paved the way for the proliferation of health. According to growing evidence from the WHO, health has improved patient lives. The expansion of the mHealth market is also influenced by the potential cost-effectiveness of medical procedures for patients and customers.

However, as the global elderly population grows rapidly, health issues like heart attacks, obesity, and chronic illnesses are becoming more common. Therefore, individuals are embracing numerous modern techniques and procedures accessible on the market to address them as they become more health-conscious about their nutritional diet and exercise programs. The popularity of buying smartwatches and numerous health applications to track daily steps taken, calories burned, and other health metrics is growing. For example, around 22% of Europe's population is senior. With a further push from private and government bodies, most of them wear a medical bracelet that alerts them for emergencies and other uses. Thus, it is anticipated that this aspect will accelerate mHealth market revenue globally.

mHealth Market Segment Insights:

mHealth Therapeutics Insights

The mHealth Market segmentation, based on therapeutics, includes respiratory, mental and neurological disorders and fitness & lifestyle. The fitness & lifestyle segment held the majority share in 2022 in the mHealth Market data with the introduction of numerous applications for fitness and lifestyle. Additionally, the use of smartphones is increasing, which is speeding up the growth of these markets. Growing interest in preventative healthcare and the resulting increase in mHealth app subscriptions have proven beneficial to the category.

Figure 2: MHealth Market, by Therapeutics, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

mHealth Manufacturing Application Insights

The mHealth Market segmentation, based on application, includes monitoring, diagnosis & treatment and wellness & prevention. The diagnosis & treatment segment dominated the market growth for mHealth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2030, due to the increased use of mHealth platforms in the accurate diagnosis and treatment of various ailments, eliminating reliance on antiquated methods of data recording. The existence of modern gadgets, such as SIMpill, which record when patients take their medications, decreases the risk of overdose and reminds them if they forget to take a dose on any given day.

mHealth Regional Insights

By region, the study provides the market insights for mHealth into North America, Europe, Asia-Pacific and Rest of the World. North America mHealth market accounted for USD 26.7 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period as a result of increased healthcare expenditures, a rise in the incidence of chronic diseases, an increase in the number of seniors, and the availability of strong network infrastructure in the area. Additionally, the region's demand for mHealth is driven by supportive government initiatives and an increase in the use of mobile healthcare applications.

Further, the major countries studied in the market report for mHealth are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: MHEALTH MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Asia Pacific mHealth market accounts for the second-largest market share. The Asia-Pacific mobile health industry is anticipated to be significantly impacted by the rising prevalence of chronic diseases. In addition, rising geriatric patient populations in nations like India and Japan are anticipated to promote regional market revenue growth. Moreover, India mHealth market held the largest market share, and the Japan mHealth market was the fastest growing market in the region.

Europe mHealth Market is expected to grow at the fastest CAGR from 2022 to 2030. The expansion of this region's market for mobile health services in Europe is being driven by an increasing number of digital health enterprises. Additionally, the prevalence of chronic health conditions, such as diabetes and cardiovascular diseases, as well as the rising demand for remote patient monitoring among those unable to access necessary medical services due to geographical constraints, are anticipated to contribute to the market's expected growth in Europe. Further, the UK mHealth market held the largest market share, and the Germany mHealth market was the fastest growing market in the region.

mHealth Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the mHealth market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the mHealth industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global mHealth industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, mHealth industry has provided medicine with some of the most significant benefits. The mHealth market major player such as Bayer healthcare, Medtronic plc, Samsung Group, Sanofi, Omron Corporation, Boston Scientific Corporation, Johnson and Johnson, Koninklijke Philips N.V., Masimo Corporation and Dexcom.

A data-based health coaching application called Livongo enables persons with diabetes to share blood glucose information with CDEs (CDEs). Feedback is given to diabetics instantly, even within minutes in an emergency. In August 2020, to develop the idea of "customer focused virtual care," Livongo Health and Teladoc Health announced a combination. The business will be able to offer a special opportunity thanks to this strategic alliance, which will also assist their data-driven platform expand.

The Samsung Group is a worldwide conglomerate of manufacturers with its headquarters at Samsung Town in Seoul. It is the largest South Korean chaebol and consists of multiple connected enterprises, the majority of which are unified under the Samsung brand (business conglomerate). Samsung will have the eighth-highest worldwide brand value in 2020. In February 2017, together with American Well, Samsung Electronics Co. bolstered the consumer-facing area with solutions for trustworthy data access in the health sector. The collaboration aims to introduce an integrated healthcare delivery system and enhance business results.

Key Companies in the mHealth market includes

• Bayer healthcare


• Medtronic plc


• Samsung Group


• Sanofi


• Omron Corporation


• Boston Scientific Corporation


• Johnson and Johnson


• Koninklijke Philips N.V.


• Masimo Corporation


• Dexcom

mHealth Industry Developments

October 2020: The U.S. Army's Medical Research and Development Command (USAMRDC) chose Fitbit, Inc., according to a press release, to create a wearable device that can identify COVID-19 early on. To develop the technology, Fitbit was given USD 2.5 million by the US Department of Defense.

September 2019: To help researchers gather information for clinical trials, Apple Inc. has released new mHealth software. Users will be able to enrol in clinical studies and securely share data with researchers via the research app on a digital health platform, which will also be used in three new national studies. The platform will be used to perform fresh research with a focus on the health of women, heart rate and mobility, and hearing.

mHealth Market Segmentation:

mHealth Type Outlook (USD Billion, 2018-2030)

• Respiratory


• Mental and Neurological disorders


• Fitness & lifestyle

mHealth Application Outlook (USD Billion, 2018-2030)

• Monitoring


• Diagnosis & Treatment


• Wellness & Prevention

mHealth Regional Outlook (USD Billion, 2018-2030)

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America